Takeda Continued Takecab Push for Hospital Doctors in January: Impact Track

Sales reps at Takeda Pharmaceutical continued their heavy pitch for the company’s acid reducer Takecab (vonoprazan) in January, with the drug making strong impressions on hospital doctors, an industry survey showed. The “Impact Track” detailing track survey, conducted by market...read more